AtaiBeckley (ATAI) Profit After Tax (2020 - 2026)
AtaiBeckley (ATAI) posted Profit After Tax of -$61.1 million for Q3 2025, down 120.2% sequentially from -$27.7 million in Q2 2025, and down 132.44% YoY from $188.4 million in Q3 2024.
Powered by 
Analysis
AtaiBeckley (ATAI) Profit After Tax (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Profit After Tax for 6 years, with the latest figure at -$61.1 million in Q3 2025.
- Quarterly Profit After Tax fell 132.44% year-over-year to -$61.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$116.3 million (down 120.44% YoY) and the FY2024 annual result came in at -$150.0 million, down 273.03% from the prior year.
- Profit After Tax for Q1 2026 stood at -$29.8 million, down from -$26.5 million in the prior quarter.
- The five-year high for Profit After Tax was -$960000.0 in Q4 2024, with the low at -$29.8 million in Q1 2026.
- The 3-year median for Profit After Tax is -$26.5 million (2025), against an average of -$19.1 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax tumbled 1028.73% in 2022, then surged 221.48% in 2023.
- AtaiBeckley's Profit After Tax stood at -$960000.0 in 2024, then sank by 2656.77% to -$26.5 million in 2025, then decreased by 12.61% to -$29.8 million in 2026.
- Business Quant data shows ATAI's Profit After Tax at -$29.8 million in Q1 2026, -$26.5 million in Q1 2025, and -$960000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -16.62 Mn |
| 10 | AtaiBeckley | 1.60 Bn | 1.60 Bn | - | -61.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.55 Mn |
| Mar 31, 2026 | -29.80 Mn |
| Sep 30, 2025 | -61.10 Mn |
| Jun 30, 2025 | -27.75 Mn |
| Jun 30, 2025 | -27.75 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Dec 31, 2024 | -960,000.00 |
| Dec 31, 2024 | -960,000.00 |
| Sep 30, 2024 | -26.31 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -27.38 Mn |
| Dec 31, 2023 | -19.14 Mn |
| Sep 30, 2023 | 44.24 Mn |
| Jun 30, 2023 | -33.77 Mn |
| Mar 31, 2023 | -34.35 Mn |
| Dec 31, 2022 | -46.65 Mn |
| Sep 30, 2022 | -35.70 Mn |
| Jun 30, 2022 | -37.51 Mn |
| Mar 31, 2022 | -37.56 Mn |